Brandy R. Matthews

11.4k total citations · 2 hit papers
36 papers, 1.6k citations indexed

About

Brandy R. Matthews is a scholar working on Psychiatry and Mental health, Physiology and Economics and Econometrics. According to data from OpenAlex, Brandy R. Matthews has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 9 papers in Physiology and 7 papers in Economics and Econometrics. Recurrent topics in Brandy R. Matthews's work include Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Brandy R. Matthews is often cited by papers focused on Dementia and Cognitive Impairment Research (15 papers), Alzheimer's disease research and treatments (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Brandy R. Matthews collaborates with scholars based in United States, United Kingdom and Germany. Brandy R. Matthews's co-authors include Bruce L. Miller, J. Scott Andrews, William W. Seeley, Noam Y. Kirson, Urvi Desai, Miriam L. Zichlin, Daniel Ball, Sherie A. Dowsett, Clifford R. Jack and Lutz Frölich and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Brandy R. Matthews

35 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

On the path to 2025: understanding the Alzheimer’s disease continuum

2017 369 citations Paul Aisen, Jeffrey L. Cummings et al. Alzheimer s Research & Therapy profile →
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

2019 221 citations J. Scott Andrews, Urvi Desai et al. Alzheimer s & Dementia Translational Research & Clinical Interventions profile →

Peers

Countries citing papers authored by Brandy R. Matthews

Since Specialization

Citations

This map shows the geographic impact of Brandy R. Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandy R. Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandy R. Matthews more than expected).

Fields of papers citing papers by Brandy R. Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandy R. Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandy R. Matthews. The network helps show where Brandy R. Matthews may publish in the future.

Co-authorship network of co-authors of Brandy R. Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Brandy R. Matthews. A scholar is included among the top collaborators of Brandy R. Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandy R. Matthews. Brandy R. Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Donanemab in early symptomatic Alzheimer’s disease: results from the TRAILBLAZER-ALZ 2 long-term extension 2025 ·The Journal of Prevention of Alzheimer s Disease ·Jennifer A. Zimmer, John R. Sims, Cynthia Evans, Emel Serap Monkul Nery, Hong Wang, Alette M. Wessels, Giulia Tronchin, Shoichiro Sato, Lars Lau Rakêt, Scott W. Andersen, Christophe Sapin, (unknown), Ivelina Gueorguieva, Paul Ardayfio, Rashna Khanna, Dawn A. Brooks, Brandy R. Matthews, Mark A. Mintun	0
2	Benefits and risks of FDA‐approved amyloid‐targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician‐patient engagement 2024 ·Alzheimer s & Dementia ·Dorene M. Rentz, Paul Aisen, Alireza Atri, Janice M. Hitchcock, Michael C. Irizarry, Jaren W. Landen, Brandy R. Matthews, (unknown), Simin Mahinrad, Salvatore Napoli, Hamid Okhravi, Ronald C. Petersen, Eric Siemers, Christopher J. Weber, (unknown), María C. Carrillo	7
3	Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019) 2023 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·J. Scott Andrews, Urvi Desai, Noam Y. Kirson, Brandy R. Matthews	3
4	The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making 2022 ·Patient ·Carol Mansfield, (unknown), (unknown), Antje Tockhorn‐Heidenreich, J. Scott Andrews, Dana DiBenedetti, Brandy R. Matthews, (unknown), (unknown), Brett Hauber	4
5	Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review 2020 ·Advances in Therapy ·Élizabeth Leroux, Andrew Buchanan, Louise Lombard, Li Shen Loo, (unknown), (unknown), (unknown), Brandy R. Matthews, Uwe Reuter	39
6	Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies 2020 ·Neurology and Therapy ·Timothy R. Smith, John H. Krege, Suchitrita S. Rathmann, Sherie A. Dowsett, Ann Marie Hake, Emel Serap Monkul Nery, Brandy R. Matthews, Erin Doty	9
7	Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014 2019 ·Journal of the American Geriatrics Society ·Noam Y. Kirson, Eric S. Meadows, Urvi Desai, Brian P. Smith, Hoi Ching Cheung, (unknown), Brandy R. Matthews	15
8	On the path to 2025: understanding the Alzheimer’s disease continuum breakdown → 2017 ·Alzheimer s Research & Therapy ·Paul Aisen, Jeffrey L. Cummings, Clifford R. Jack, John C. Morris, Reisa A. Sperling, Lutz Frölich, Roy Jones, Sherie A. Dowsett, Brandy R. Matthews, Joel Raskin, Philip Scheltens, Bruno Dubois	369
9	Apolipoprotein ε4 Is Associated with Lower Brain Volume in Cognitively Normal Chinese but Not White Older Adults 2015 ·PLoS ONE ·Jennifer S. Yokoyama, (unknown), Leonel Tadao Takada, Edgar Busovaca, Luke W. Bonham, Steven Chao, (unknown), Jing He, Christopher G. Schwarz, Owen Carmichael, Brandy R. Matthews, Anna Karydas, Michael W. Weiner, Giovanni Coppola, Charles DeCarli, Bruce L. Miller, Howard J. Rosen	13
10	Memory Dysfunction 2015 ·CONTINUUM Lifelong Learning in Neurology ·Brandy R. Matthews	29
11	Depressive Symptoms in Chinese-American Subjects with Cognitive Impairment 2013 ·American Journal of Geriatric Psychiatry ·Steven Chao, Brandy R. Matthews, Jennifer S. Yokoyama, (unknown), (unknown), (unknown), (unknown), Amy Lin, Joel H. Kramer, Kristine Yaffe, John Kornak, Bruce L. Miller, Howard J. Rosen	14
12	Frontotemporal Lobar Degeneration 2012 ·CNS Drugs ·(unknown), Brandy R. Matthews	100
13	Frontotemporal dementia in eight Chinese individuals 2012 ·Neurocase ·Steven Chao, Howard J. Rosen, (unknown), (unknown), (unknown), (unknown), Craig E. Hou, William W. Seeley, Bruce L. Miller, Brandy R. Matthews	6
14	Light chain (AL) amyloidosis in the central nervous system (CNS) 2011 ·Amyloid ·M D Benson, Thomas C. Witt, José M. Bonnin, Brandy R. Matthews, Rafat Abonour	2
15	Bravo! Neurology at the Opera 2010 ·Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences ·Brandy R. Matthews	2
16	Portrayal of Neurological Illness and Physicians in the Works of Shakespeare 2010 ·Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences ·Brandy R. Matthews	3
17	Chapter 23 The musical brain 2008 ·Handbook of clinical neurology ·Brandy R. Matthews	1
18	Unravelling Boléro: progressive aphasia, transmodal creativity and the right posterior neocortex 2007 ·Brain ·William W. Seeley, Brandy R. Matthews, (unknown), Maria Luisa Gorno‐Tempini, Dean Foti, Ian R. Mackenzie, Bruce L. Miller	131
19	Cerebellar Ataxia and Central Nervous System Whipple Disease 2005 ·Archives of Neurology ·Brandy R. Matthews, Lyell K. Jones, (unknown), Allen J. Aksamit, Keith A. Josephs	35
20	Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease 2003 ·American Journal of Geriatric Psychiatry ·Brandy R. Matthews, Eric Siemers, P. David Mozley	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact